Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 8943-8951

  Lewis, J ^a   Balfe, P ^b   Arnold, C ^c   Kaye, S ^b   Tedder, R S ^b   Mckeating, J A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; GAG PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; HUMORAL IMMUNE DEFICIENCY; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION;

EID: 0031661153     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.8943-8951.1998     Document Type: Article

References (77)

1. Ait-Khaled, M., and V. C. Emery. 1993. Sequence variation within the human immunodeficiency virus V3 loop at seroconversion. J. Med. Virol. 41:270-274.
2. Albert, J., B. Abrahamsson, K. Nagy, E. Aurelius, H. Gaines, G. Nystrom, and E. M. Fenyö. 1990. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112.
3. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC-CKR-5 - a RANTES, MIP-1-alpha, MIP-1-beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
4. Arnold, C. 1996. Ph.D. thesis. University College London, London, United Kingdom.
5. Arnold, C., P. Balfe, and J. P. Clewley. 1995. Sequence distances between Env genes of HIV-1 from individuals infected from the same source -implications for the investigation of possible transmission events. Virology 211:198-203.
6. Binley, J. M., P. J. Klasse, Y. Z. Cao, I. Jones, M. Markowitz, D. D. Ho, and J. P. Moore. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71:2799-2809.
7. Biti, R., R. French, J. Young, B. Bennetts, and G. Stewart. 1997. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat. Med. 3:252-253.
8. Bleul, C. C., L. J. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR-4 and CCR-5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930.
9. Bolognesi, D. 1994. Humoral immune responses to primary HIV isolates: implications for vaccine development. Neuvieme Colloque des Cent Gardes Paris 1994:285-291.
10. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
11. Borrow, P., H. Lewicki, X. P. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. A. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
12. Cheynier, R., S. Henrichwark, F. Hadida, E. Pelletier, E. Oksenhendler, B. Autran, and S. Wain Hobson. 1994. HIV and T-cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T-lymphocytes. Cell 78:373-387.
13. Choe, H., M. Farzun, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, and N. Gerard. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1136-1148.
14. Clapham, P. R., A. McKnight, and R. A. Weiss. 1992. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J. Virol. 66:3531-3537.
15. Clark, S. J., M. S. Saag, W. D. Decker, S. Campbellhill, J. L. Robertson, P. J. Veldkamp, J. C. Kappes, B. H. Hahn, and G. M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
16. Connor, R. I., and D. D. Ho. 1994. Transmission and pathogenesis of human immunodeficiency virus type-1. AIDS Res. Hum. Retroviruses 10:321-323.
17. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type-1 infection. N. Engl. J. Med. 324:961-964.
18. Dean, M., M. Carrington, C. Winkler, G. A. Huttley, M. W. Smith, R. Allikmets, J. J. Goedert, S. P. Buchbinder, E. Vittinghof, E. Gomperts, S. Donfield, D. Vlahov, R. Kaslow, A. Saah, C. Rinaldo, R. Detels, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and S. J. O'Brien. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR-5 structural gene. Science 273: 1856-1861.
19. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Dimarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major coreceptor for primary isolates of HIV-1. Nature 381:661-666.
20. Dittmar, M. T., G. Simmons, S. Hibbitts, M. O'Hare, S. Louisirirotchanakul, S. Beddows, J. Weber, P. R. Clapham, and R. A. Weiss. 1997. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J. Virol. 71: 8008-8013.
21. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
22. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-671.
23. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor - functional cDNA cloning of a 7-transmembrane, G-protein-coupled receptor. Science 272:872-877.
24. Ferbas, J., E. S. Daar, K. Grovitferbas, W. J. Lech, R. Detels, J. V. Giorgi, and A. H. Kaplan. 1996. Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J. Virol. 70:7285-7289.
25. Fiore, J. R., A. Bjorndal, K. A. Peipke, M. Distefano, G. Angarano, G. Pastore, H. Gaines, E. M. Fenyö, and J. Albert. 1994. The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204:297-303.
26. Fox, D. G., P. Balfe, C. Palmer, J. May, C. Arnold, and J. McKeating. 1997. Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site. J. Virol. 71:759-765.
27. Goudsmit, J., A. De Ronde, E. De Rooij, and R. De Boer. 1997. Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215. J. Virol. 71: 4479-4484.
28. Goudsmit, J., G. Zwart, and T. Wolfs. 1992. Assessment of HIV-1 antigenic diversification using serum as sample source. AIDS Res. Hum. Retroviruses 8:1473.
29. Groenink, M., A. C. Andeweg, R. A. M. Fouchier, S. Broersen, R. C. M. Vanderjagt, H. Schuitemaker, R. E. Y. De Goede, M. L. Bosch, H. G. Huisman, and M. Tersmette. 1992. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. J. Virol. 66:6175-6180.
30. Helseth, E., U. Olshevsky, C. Furman, and J. Sodroski. 1991. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65:2119-2123.
31. Jurriaans, S., B. Vangemen, G. J. Weverling, D. Vanstrijp, P. Nara, R. Coutinho, M. Koot, H. Schuitemaker, and J. Goudsmit. 1994. The natural history of HIV-1 infection - virus load and virus phenotype independent determinants of clinical course. Virology 204:223-233.
32. Kaye, S., C. Loveday, and R. S. Tedder. 1992. A microtitre format point mutation assay - application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J. Med. Virol. 37:241-246.
33. Keet, I. P. M., P. Krijnen, M. Koot, J. M. A. Lange, F. Miedema, J. Goudsmit, and R. A. Coutinho. 1993. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 7:51-57.
34. Koup, R. A., J. T. Safrit, Y. Z. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
35. Kuiken, C. L., V. V. Lukashov, E. Baan, J. Dekker, J. A. M. Leunissen, and J. Goudsmit. 1996. Evidence for limited within-person evolution of the V3 domain of the HIV-1 envelope in the Amsterdam population. AIDS 10:31-37.
36. Lathey, J. L., R. D. Pratt, and S. A. Spector. 1997. Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1. J. Infect. Dis. 175:231-232.
37. Liu, R., W. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlman, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiple-exposed individuals to HIV-1 infection. Cell 86:367-377.
38. Loestcher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J.-M. Dayer. 1998. CCR-5 is characteristic of Th1 lymphocytes. Nature 391:344-345.
39. McKeating, J. A., J. Bennett, S. Zolla Pazner, M. Schutten, S. Ashelford, A. Leigh Brown, and P. Balfe. 1993. Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino-acid change in gp120. J. Virol. 67:5216-5225.
40. McKeating, J. A., Y. J. Zhang, C. Arnold, R. Frederiksson, E. M. Fenyö, and P. Balfe. 1996. Biological characterization of T-cell adapted clones of human immunodeficiency virus type 1 expressing primary envelope glycoproteins. Virology 220:450-460.
41. McKnight, A., P. R. Clapham, J. Goudsmit, R. Cheingsongpopov, J. N. Weber, and R. A. Weiss. 1992. Development of HIV-1 group-specific neutralizing antibodies after seroconversion. AIDS 6:799-802.
42. Moog, C., H. J. A. Fleury, I. Pellegrin, A. Kirn, and A. M. Aubertin. 1997. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. J. Virol. 71:3734-3741.
43. Moore, J. P. 1990. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. AIDS 4:297-305.
44. Moore, J. P., Y. Z. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
45. Moore, J. P., and P. L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection. AIDS 5(Suppl. 2):S21-S33.
46. Moore, J. P., R. L. Willey, G. K. Lewis, J. Robinson, and J. Sodroski. 1994. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68:6836-6847.
47. Murphy, A. 1998. Ph.D. thesis. University of Reading, Reading, United Kingdom.
48. Myers, G., B. Korber, S. Wain-Hobson, K. T. Jeang, L. E. Henderson, and G. N. Pavlakis. 1994. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
49. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
50. Orloff, S. L., C. I. Bandea, M. S. Kennedy, G. P. Allaway, P. J. Maddon, and J. S. McDougal. 1995. Increase in sensitivity to soluble CD4 by primary HIV type-1 isolates after passage through C8166 cells - association with sequence differences in the first constant (C1) region of glycoprotein-120. AIDS Res. Hum. Retroviruses 11:335-342.
51. Palmer, C., P. Balfe, D. G. Fox, J. C. May, R. Frederiksson, E. M. Fenyö, and J. A. McKeating. 1996. Functional characteristics of the V1V2 region of human immunodeficiency virus type 1. Virology 220:436-449.
52. Pantaleo, G., O. J. Cohen, T. Schacker, M. Vaccarezza, C. Graziosi, G. Paolo Rizzardi, J. Kahn, C. H. Fox, S. M. Schnittman, D. H. Schwartz, L. Corey, and A. S. Fauci. 1998. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: implications for antiviral therapy. Nat. Med. 4:341-345.
53. Pantaleo, G., C. Graziosi, J. F. Demarest, O. J. Cohen, M. Vaccarezza, K. Gantt, C. Murocacho, and A. S. Fauci. 1994. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol. Rev. 140:105-130.
54. Patterson, S., N. R. English, H. Longhurst, P. Balfe, M. Helbert, A. J. Pinching, and S. C. Knight. 1998. Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1-infected patients. J. Gen. Virol. 79:247-257.
55. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. Van-Devanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412-417.
56. Pilgrim, A. K., G. Pantaleo, O. J. Cohen, L. M. Fink, J. Y. Zhou, J. T. Zhou, D. P. Bolognesi, A. S. Fauci, and D. C. Montefiori. 1997. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176:924-932.
57. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1. J. Virol. 72: 2855-2864.
58. Pope, M., S. S. Frankel, J. R. Mascola, A. Trkola, F. Isdell, D. L. Birx, D. S. Burke, D. D. Ho, and J. P. Moore. 1997. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J. Virol. 71:8001-8007.
59. Roos, M. T. L., J. M. A. Lange, R. E. Y. De Goede, R. A. Coutinho, P. T. A. Schellekens, F. Miedema, and M. Tersmette. 1992. Viral phenotype and immune response in primary human immunodeficiency virus type-1 infection. J. Infect. Dis. 165:427-432.
60. Safrit, J. T., C. A. Andrews, T. F. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1 specific cytotoxic T-lymphocyte clones isolated during acute seroconversion - recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
61. Salminen, M., A. Nykanen, and P. Leinikki. 1993. Solid-phase direct genomic sequencing and phylogenetic analysis reveal 4 major HIV-1 lineages in Finland. J. Cell. Biochem. S17E SIE:85.
62. Samson, M., F. Libert, B. J. Doranz, J. Rucker, C. Liesnard, C. M. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, G. Muyldermans, C. Verhofsteede, G. Burtonboy, M. Georges, T. Imai, S. Rana, Y. Yi, R. J. Smyth, R. G. Collman, R. W. Doms, G. Vassart, and M. Parmentier. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
63. Scarlatti, G., J. Albert, P. Rossi, V. Hodara, P. Biraghi, L. Muggiasca, and E. M. Fenyö. 1993. Mother-to-child transmission of human immunodeficiency virus type-1 - correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:207-210.
64. Scarlatti, G., E. Tresoldi, A. Björadal, R. Frederiksson, C. Colognesi, H. K. Deng, M. S. Malnati, A. Plebani, A. G. Siccardi, D. R. Littman, E. M. Fenyö, and P. Lusso. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259-1265.
65. Schols, D., J. A. Esté, C. Cabrera, and E. De Clercq. 1998. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1α contains mutations in the envelope gp120 but does not show a switch in coreceptor use. J. Virol. 72:4032-4037.
66. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. Y. De Goede, R. P. Vansteenwijk, J. M. A. Lange, J. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
67. Schuitemaker, H., N. A. Kootstra, R. E. Y. De Goede, F. De Wolf, F. Miedema, and M. Tersmette. 1991. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell-line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:356-363.
68. Shotton, C., C. Arnold, Q. J. Sattentau, J. Sodroski, and J. A. McKeating. 1995. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 69:222-230.
69. Smyth, R. J., Y. Yi, A. Singh, and R. G. Collman. 1998. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate. J. Virol. 72:4478-4484.
70. Soto Ramirez, L. E., B. Renjifo, M. F. McLane, R. Marlink, C. O'Hara, R. Sutthent, C. Wasi, P. Vithayasai, V. Vithayasai, C. Apichartpiyakul, P. Auewarakul, V. P. Cruz, D. S. Chui, R. Osathanondh, K. Mayer, T. H. Lee, and M. Essex. 1996. HIV-1 Langerhans cell tropism associated with heterosexual transmission of HIV. Science 271:1291-1293.
71. Spear, G. T., D. M. Takefman, S. Sharpe, M. Ghassemi, and S. Zolla Pazner. 1994. Antibodies to the HIV-1 V3 loop in serum from infected persons contribute a major proportion of immune effector functions including complement activation, antibody-binding, and neutralization. Virology 204:609-615.
72. Tersmette, M., R. A. Gruters, F. De Wolf, R. E. De Goede, J. M. Lange, P. T. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
73. Tsang, M. L., L. A. Evans, P. McQueen, L. Hurren, C. Byrne, and C. D. Penny. 1994. Neutralizing antibodies against sequential autologous human immunodeficiency virus type-1 isolates after seroconversion. J. Infect. Dis. 170:1141-1147.
74. Weber, J., E. M. Fenyö, S. Beddows, P. Kaleebu, A. Björndal, S. Osmanov, W. Heyward, J. Esparza, B. Galvaocastro, P. Vandeperre, E. Karita, C. Wasi, S. Sempala, B. Tugume, B. Biryahwaho, H. Rübsamen Waigmann, H. Von Briesen, R. Esser, M. Grez, H. Holmes, A. Newberry, S. Ranjbar, P. Tomlinson, J. Bradac, F. McCutchan, J. Louwagie, P. Hegerich, C. Lopez Galindez, I. Olivares, J. Dopazo, J. I. Mullins, E. L. Delwart, H. M. Bachmann, J. Goudsmit, F. De Wolf, B. H. Hahn, F. Gao, L. Yue, S. Saragosti, G. Schochetman, M. Kalish, C. C. Luo, R. George, C. P. Pau, R. Cheingsongpopov, P. Nara, J. Albert, G. Myers, and B. Korber. 1996. Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. J. Virol. 70:7827-7832.
75. Wu, L. J., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1681-1691.
76. Zhang, L. Q., P. Mackenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
77. Zhu, T. F., N. Wang, A. Carr, D. S. Nam, R. Moorjankowski, D. A. Cooper, and D. D. Ho. 1996. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J. Virol. 70:3098-3107.